Nota: Para mayor información de las referencia bibliográficas y evidencia asociada a las recomendaciones, favor remitirse a la versión completa de esta guía.

1. Ángel-Müller E, González MP, Núñez L., Pacheco J, Tolosa J E., Díaz LA, et al. Frecuencia de infecciones del tracto genital femenino en mujeres sintomáticas y uso de pruebas rápidas para su diagnóstico en dos poblaciones de Bogotá (Colombia) 2008: Estudio piloto. Rev Colomb Obstet Ginecol 2010;61(3):220- 30.
2. Workowski KA, Berman S. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2010;59(RR 12):1-110.
3. UnAIDS/WHO. Sexually transmitted diseases: policies and principles for prevention and care. . UnAIDS Best Practice Collection Key Material Geneva: UnAIDS/ WHO. 1999.
4. OMS. Guías para el tratamiento de las infecciones de transmisión sexual. Organización Mundial de la Salud; 2005.
5. WHO. World Health Organization. Sexually transmitted infections. Fact sheet August 2011.
6. Johnson L, Bradshaw D, Dorrington R. South African Comparative Risk Assessment Collaborating Group. The burden of disease attributable to sexually transmitted infections in South Africa in 2000. S Afr Med J. 2007;97(8):658-62.
7. Acosta J P, Rodriguez D, C. R. Situacion de las enfermedades de transmision sexual, Colombia,1976-2000. Biomédica. 2002;22(1):77- 88.
8. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol. 2000 Oct;19(1-2):1-5.
9. Trei JS, Canas LC, Gould PL. Reproductive tract complications associated with Chlamydia trachomatis infection in US Air Force males within 4 years of testing. Sex Transm Dis. 2008 Sep;35(9):827-33.
10. Pultorak E, Wong W, Rabins C, Mehta SD. Economic burden of sexually transmitted infections: incidence and direct medical cost of Chlamydia, gonorrhea, and syphilis among Illinois adolescents and young adults, 2005- 2006. Sex Transm Dis. 2009 Oct;36(10):629-36.
11. Ministerio_de_Salud, Republica_de_Colombia. Guía de Atención de Enfermedades de Transmisión Sexual. Resolución Número 412 De 2000. . . 2000.
12. Lewis DA, Lukehart SA. Antimicrobial resistance in Neisseria gonorrhoeae and Treponema pallidum: evolution, therapeutic challenges and the need to strengthen global surveillance. Sex Transm Infect. 2011;87(2): 39-44.
13. RCOG. Management of acute pelvic inflammatory disease – Green Top Guideline No.32. Royal College of Obstetricians and Gynaecologist. 2008.
14. PHAC. Canadian Guidelines on Sexually Transmitted Infections. Public Health Agency of Canada.; 2010.
15. Ng BE, Butler LM, Horvath T, Rutherford GW. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection. Cochrane Database Syst Rev. 2011(3):CD001220.
16. NIAID. Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. 2001(Available at www.¬port.pdf.).
17. Wilkinson D, Ramjee G, Tholandi M, Rutherford G. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men. Cochrane Database Syst Rev. 2002(4):CD003939.
18. Padian NS, Buve A, Balkus J, Serwadda D, Cates W, Jr. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet. 2008 Aug 16;372(9638):585-99.
19. IUSTI-WHO. European STD guidelines Int J STD AIDS. Suppl 3:2-3; 2001. p. 1-94.
20. Trelle S, Shang A, Nartey L, Cassell JA, Low N. Improved effectiveness of partner notification for patients with sexually transmitted infections: systematic review. BMJ. 2007 Feb 17;334(7589):354.
21. Chin HB, Sipe TA, Elder R, Mercer SL, Chattopadhyay SK, Jacob V, et al. The effectiveness of group-based comprehensive risk-reduction and abstinence education interventions to prevent or reduce the risk of adolescent pregnancy, human immunodeficiency virus, and sexually transmitted infections: two systematic reviews for the Guide to Community Preventive Services. Am J Prev Med. 2012 Mar;42(3):272-94.
22. Nuñez L, Moyano L, Gaitán H, Tolosa J, Ángel E, et_al. Exactitud de las pruebas rápidas para C. trachomatis, N. gonorrhoeae y sífilis a ser aplicadas en el punto de cuidado en mujeres con signos de infección del tracto genital inferior en Bogotá, Colombia 2010. Convocatoria 493 de Colciencias. Artículo en preparación.
23. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002 Sep;29(9):497-502.
24. Sendag F, Terek C, Tuncay G, Ozkinay E, Guven M. Single dose oral azithromycin versus seven day doxycycline in the treatment of non-gonococcal mucopurulent endocervicitis. Aust N Z J Obstet Gynaecol. 2000 Feb;40(1):44-7.
25. Guven MA, Gunyeli I, Dogan M, Ciragil P, Bakaris S, Gul M. The demographic and behavioural profile of women with cervicitis infected with Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum and the comparison of two medical regimens. Arch Gynecol Obstet. 2005 Sep;272(3):197-200.
26. Rustomjee R, Kharsany AB, Connolly CA, Karim SS. A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. J Antimicrob Chemother. 2002 May;49(5):875-8.
27. Bai Z, Bao X, WD WC, KH KY, Li Y. Efficacy and safety of ceftriaxone for uncomplicated gonorrhoea: a meta-analysis of randomized controlled trials. . Int J STD AIDS. 2012;23(2):126-32.
28. Shams ur R, Khan A, Amanullah, Akhter K. Clinical efficacy of the various drugs used in the treatment of gonorrhoeae. J Ayub Med Coll Abbottabad. 2009 Oct-Dec;21(4):28-30.
29. Crosby Ra, DiClemente RJ, Wingood GM, Salazar LF, Rose E, Levine D, et al. Associations Between Sexually Transmitted Disease Diagnosis and Subsequent Sexual Risk and Sexually Transmitted Disease Incidence Among Adolescents. Sexually Transmitted Diseases. 2004;31(4):205-8.
30. Schillinger JA, Kissinger P, Calvet H, Whittington WL, Ransom RL, Sternberg MR, et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis. 2003 Jan;30(1):49- 56.
31. Golden MR, Whittington WL, Handsfield HH, Hughes JP, Stamm WE, Hogben M, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med. 2005 Feb 17;352(7):676-85.
32. Brocklehurst P, Rooney G. Interventions for treating genital chlamydia trachomatis infection in pregnancy. Cochrane Database Syst Rev. 2000(2):CD000054.
33. Pitsouni E, Iavazzo C, Athanasiou S, Falagas ME. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents. 2007 Sep;30(3):213-21.
34. Turrentine MA, Newton ER. Amoxicillin or erythromycin for the treatment of antenatal chlamydial infection: a meta-analysis. Obstet Gynecol. 1995 Dec;86(6):1021-5.
35. Brocklehurst P. Antibiotics for gonorrhoea in pregnancy. Cochrane Database Syst Rev. 2002(2):CD000098.
36. Cavenee MR, Farris JR, Spalding TR, Barnes DL, Castaneda YS, Wendel GD. Treatment of gonorrhea in pregnancy. Obstet Gynecol. 1993 Jan;81(1):33-8.
37. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2007(1):CD000262.
38. Takahashi S, Ichihara K, Hashimoto J, Kurimura Y, Iwasawa A, Hayashi K, et al. Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother. 2011;17(3):392-6.
39. Schwebke J, Rompalo A, Taylor S, Seña A, Martin D, Lopez L, et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens–a randomized clinical trial. Clin Infect Dis. 2012;52(2):163-70.
40. Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med. 1997 Jul 31;337(5):307-14.
41. Bai Z, Wang B, Yang K, Tian J, Ma B, Liu Y, et al. Azithromycin versus penicillin G benzathine for early syphilis. CochraneDatabase of Systematic Reviews 2012(6):CD007270.
42. Bai ZG, Yang KH, Liu YL, Tian JH, Ma B, Mi DH, et al. Azithromycin vs. benzathine penicillin G for early syphilis: a meta-analysis of randomized clinical trials. Int J STD AIDS. 2008 Apr;19(4):217-21.
43. Tucker JD, Bu J, Brown LB, Yin YP, Chen XS, Cohen MS. Accelerating worldwide syphilis screening through rapid testing: a systematic review. Lancet Infect Dis. 2010 Jun;10(6):381-6.
44. Moorthy TT, Lee CT, Lim KB, Tan T. Ceftriaxone for treatment of primary syphilis in men: a preliminary study. Sex Transm Dis. 1987 Apr- Jun;14(2):116-8.
45. Martin DH, Sargent SJ, Wendel GD, Jr., McCormack WM, Spier NA, Johnson RB. Comparison of azithromycin and ceftriaxone for the treatment of chancroid. Clin Infect Dis. 1995 Aug;21(2):409-14.
46. Tyndall MW, Agoki E, Plummer FA, Malisa W, Ndinya-Achola JO, Ronald AR. Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin. Sex Transm Dis. 1994 Jul-Aug;21(4):231-4.
47. Malonza IM, Tyndall MW, Ndinya-Achola JO, Maclean I, Omar S, MacDonald KS, et al. A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. J Infect Dis. 1999 Dec;180(6):1886-93.
48. Banov L, Jr. Rectal strictures of lymphogranuloma venereum; some observations from a five-year study of treatment with the broad spectrum antibiotics. Am J Surg. 1954 Nov;88(5):761-7.
49. Greaves AB, Hilleman MR, Taggart SR, Bankhead AB, Feld M. Chemotherapy in bubonic lymphogranuloma venereum: a clinical and serological evaluation. Bull World Health Organ. 1957;16(2):277-89.
50. Martin DH, Mroczkowski TF, Dalu ZA, McCarty J, Jones RB, Hopkins SJ, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med. 1992 Sep 24;327(13):921-5.
51. Thorpe EM, Jr., Stamm WE, Hook EW, 3rd, Gall SA, Jones RB, Henry K, et al. Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises. Genitourin Med. 1996 Apr;72(2):93-7.
52. Robinson HM, Jr., Cohen MM. Treatment of granuloma inguinale with erythromycin. J Invest Dermatol. 1953 Jun;20(6):407-9.
53. Greenblatt RB, Barfield WE, Dienst RB, West RM. Terramycin in treatment of granuloma inguinale. J Vener Dis Inf. 1951 May;32(5):113-5.
54. Bowden FJ, Mein J, Plunkett C, Bastian I. Pilot study of azithromycin in the treatment of genital donovanosis. Genitourin Med. 1996 Feb;72(1):17-9.
55. Bryson YJ, Dillon M, Lovett M, Acuna G, Taylor S, Cherry JD, et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med. 1983 Apr 21;308(16):916-21.
56. Mertz GJ, Critchlow CW, Benedetti J, Reichman RC, Dolin R, Connor J, et al. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA. 1984 Sep 7;252(9):1147-51.
57. Nilsen AE, Aasen T, Halsos AM, Kinge BR, Tjotta EA, Wikstrom K, et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet. 1982 Sep 11;2(8298):571-3.
58. Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Sex Transm Dis. 1997 Sep;24(8):481-6.
59. Lebrun-Vignes B, Bouzamondo A, Dupuy A, Guillaume JC, Lechat P, Chosidow O. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks. J Am Acad Dermatol. 2007 Aug;57(2):238-46.
60. Wong T, Singh AE, De P. Primary syphilis: serological treatment response to doxycycline/tetracycline versus benzathine penicillin. Am J Med. 2008 Oct;121(10):903-8.
61. Mathews C, Coetzee N, Zwarenstein M, Lombard C, Guttmacher S, Oxman A, et al. Strategies for partner notification for sexually transmitted diseases. Cochrane Database Syst Rev. 2001(4):CD002843.
62. Blencowe H, Cousens S, Kamb M, Berman S, Lawn JE. Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public Health. 2011;11 Suppl 3:S9.
63. Walker GJ. Antibiotics for syphilis diagnosed during pregnancy. Cochrane Database Syst Rev. 2001(3):CD001143.
64. Eckert LO. Clinical practice. Acute vulvovaginitis. N Engl J Med. 2006 Sep 21;355(12):1244-52.
65. Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev. 2009(3):CD006055.
66. Bohbot JM, Vicaut E, Fagnen D, Brauman M. Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole. Infect Dis Obstet Gynecol. 2010;2010.
67. Sherrard J, Donders G, White D, Jensen J, IUSTI E. European (IUSTI/WHO) guideline on the management of vaginal discharge, 2011. Int J STD AIDS. 2011;22(8).
68. Schwebke J, Desmond R. Tinidazole vs metronidazole for the treatment of bacterial vaginosis. Am J Obstet Gynecol. 2011;204(3):211.e1-6.
69. Forna F, Gulmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev. 2003(2):CD000218.
70. Nurbhai M, Grimshaw J, Watson M, Bond C, Mollison J, Ludbrook A. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev. 2007(4):CD002845.
71. Pepin J. Low prevalence of cervical infections in women with vaginal discharge in west Africa: implications for syndromic management. Sexually transmitted infections. 2004;80(3):230-5.
72. Lamont R, Nhan-Chang C, Sobel J, Workowski K, Conde-Agudelo A, Romero R. Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;205(3):177-90.
73. Gulmezoglu AM, Azhar M. Interventions for trichomoniasis in pregnancy. Cochrane Database Syst Rev. 2011(5):CD000220.
74. Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodriguez Pinilla E. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol. 1997 Aug;44(2):179-82.
75. Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database Syst Rev. 2001(4):CD000225.
76. Lyng J, Christensen J. A double-blind study of the value of treatment with a single dose tinidazole of partners to females with trichomoniasis. Acta Obstet Gynecol Scand. 1981;60(2):199-201.
77. Spence D. Candidiasis (vulvovaginal). Clin Evid (Online). 2010;2010.
78. Sobel JD, Ferris D, Schwebke J, Nyirjesy P, Wiesenfeld HC, Peipert J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006 May;194(5):1283-9.
79. Kanno M, Sobel JD. Late recurrence of resistant Trichomonas vaginalis vaginitis: relapse or re-infection? Sex Transm Infect. 2003 Jun;79(3):260-1.
80. Hager WD. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients. Sex Transm Dis. 2004 Jun;31(6):343-5.
81. Saporiti AM, Gomez D, Levalle S, Galeano M, Davel G, Vivot W, et al. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use]. Rev Argent Microbiol. 2001 Oct-Dec;33(4):217-22.
82. Stewart A, Ubee SS, Davies H. Epididymo-orchitis. BMJ. 2011;342:d1543.
83. Morcos R, Frost N, Hnat M, Petrunak A, Caldito G. Laparoscopic versus clinical diagnosis of acute pelvic inflammatory disease. J Reprod Med. 1993 Jan;38(1):53-6.
84. Cibula D, Kuzel D, Fucikova Z, Svabik K, Zivny J. Acute exacerbation of recurrent pelvic inflammatory disease. Laparoscopic findings in 141 women with a clinical diagnosis. J Reprod Med. 2001 Jan;46(1):49-53.
85. Molander P, Finne P, Sjoberg J, Sellors J, Paavonen J. Observer agreement with laparoscopic diagnosis of pelvic inflammatory disease using photographs. Obstet Gynecol. 2003 May;101(5 Pt 1):875-80.
86. Gaitan H, Angel E, Diaz R, Parada A, Sanchez L, Vargas C. Accuracy of five different diagnostic techniques in mild-to-moderate pelvic inflammatory disease. Infect Dis Obstet Gynecol. 2002;10(4):171-80.
87. Bevan CD, Johal BJ, Mumtaz G, Ridgway GL, Siddle NC. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. Br J Obstet Gynaecol. 1995 May;102(5):407-14.
88. Kinghorn GR, Duerden BI, Hafiz S. Clinical and microbiological investigation of women with acute salpingitis and their consorts. Br J Obstet Gynaecol. 1986 Aug;93(8):869-80.
89. Molander P, Sjoberg J, Paavonen J, Cacciatore B. Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease. Ultrasound Obstet Gynecol. 2001 Mar;17(3):233-8.
90. Taipale P, Tarjanne H, Ylostalo P. Transvaginal sonography in suspected pelvic inflammatory disease. Ultrasound Obstet Gynecol. 1995 Dec;6(6):430-4.
91. Tukeva TA, Aronen HJ, Karjalainen PT, Molander P, Paavonen T, Paavonen J. MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology. 1999 Jan;210(1):209-16.
92. Imaoka I, Wada A, Matsuo M, Yoshida M, Kitagaki H, Sugimura K. MR imaging of disorders associated with female infertility: use in diagnosis, treatment, and management. Radiographics. 2003 Nov-Dec;23(6):1401-21.
93. Nishino M, Hayakawa K, Iwasaku K, Takasu K. Magnetic resonance imaging findings in gynecologic emergencies. J Comput Assist Tomogr. 2003 Jul- Aug;27(4):564-70.
94. Ness RB, Soper DE, Richter HE, Randall H, Peipert JF, Nelson DB, et al. Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study. Sex Transm Dis. 2008 Feb;35(2):129-35.
95. Lepine LA, Hillis SD, Marchbanks PA, Joesoef MR, Peterson HB, Westrom L. Severity of pelvic inflammatory disease as a predictor of the probability of live birth. Am J Obstet Gynecol. 1998 May;178(5):977-81.
96. Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W, Jr., Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol. 1993 May;168(5):1503-9.
97. Martens MG, Gordon S, Yarborough DR, Faro S, Binder D, Berkeley A. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group. South Med J. 1993 Jun;86(6):604-10.
98. Walker CK, Kahn JG, Washington AE, Peterson HB, Sweet RL. Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy. J Infect Dis. 1993 Oct;168(4):969-78.
99. Arredondo JL, Diaz V, Gaitan H, Maradiegue E, Oyarzun E, Paz R, et al. Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients. Clin Infect Dis. 1997 Feb;24(2):170-8.
100. Hemsell DL, Little BB, Faro S, Sweet RL, Ledger WJ, Berkeley AS, et al. Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease. Clin Infect Dis. 1994 Oct;19(4):720-7.
101. Savaris RF, Teixeira LM, Torres TG, Edelweiss MI, Moncada J, Schachter J. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial. Obstet Gynecol. 2007 Jul;110(1):53-60.
102. Bevan CD, Ridgway GL, Rothermel CD. Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease. J Int Med Res. 2003 Jan-Feb;31(1):45-54.
103. ESG. Comparative evaluation of clindamycin/gentamicin and cefoxitin/ doxycycline for treatment of pelvic inflammatory disease: a multi-center trial. The European Study Group. Acta Obstet Gynecol Scand. 1992 Feb;71(2):129-34.
104. Altunyurt S, Demir N, Posaci C. A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol. 2003 Mar 26;107(1):81-4.
105. Soderberg G, Lindgren S. Influence of an intrauterine device on the course of an acute salpingitis. Contraception. 1981 Aug;24(2):137-43.
106. Corsi PJ, Johnson SC, Gonik B, Hendrix SL, McNeeley SG, Jr., Diamond MP. Transvaginal ultrasound-guided aspiration of pelvic abscesses. Infect Dis Obstet Gynecol. 1999;7(5):216-21.
107. Aboulghar MA, Mansour RT, Serour GI. Ultrasonographically guided transvaginal aspiration of tuboovarian abscesses and pyosalpinges: an optional treatment for acute pelvic inflammatory disease. Am J Obstet Gynecol. 1995 May;172(5):1501-3.
108. Haddon L, Heason J, Fay T, McPherson M, Carlin EM, Jushuf IH. Managing STIs identified after testing outside genitourinary medicine departments: one model of care. Sex Transm Infect. 1998 Aug;74(4):256-7.
109. Groom TM, Stewart P, Kruger H, Bell G. The value of a screen and treat policy for Chlamydia trachomatis in women attending for termination of pregnancy. J Fam Plann Reprod Health Care. 2001 Apr;27(2):69-72.
110. Ross JD. What is endometritis and does it require treatment? Sex Transm Infect. 2004 Aug;80(4):252-3.
111. Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. London: National Institute for Clinical Excellence. Journal [serial on the Internet]. (February 2004, updated 2005) Date: Available from:
112. Elaboración de Guías de Práctica Clínica en el Sistema Nacional de Salud. Manual Metodológico [Internet]. Madrid: Plan Nacional para el SNS del MSC. Journal [serial on the Internet]. 2007 Date; (Guías de Práctica Clínica en el SNS: I+CS Nº 2006/0I, p. 10. ): Available from: http://portal.guiasalud. es/emanuales/elaboracion/index-02.htm, [Fecha de consulta: 11/01/2011]. .




Por favor ingrese su comentario!